ClinicalTrials.Veeva

Menu

Effect of Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in Cirrhotic Patients With Hepatopulmonary Syndrome

S

Sichuan University

Status

Completed

Conditions

Hepatopulmonary Syndrome

Treatments

Procedure: Transjugular intrahepatic portosystemic shunt

Study type

Observational

Funder types

Other

Identifiers

NCT02148536
WCH-2014-034

Details and patient eligibility

About

To prospectively investigate the effect of transjugular intrahepatic portosystemic shunt (TIPS) on oxygenation in cirrhotic patients with hepatopulmonary syndrome (HPS).

Enrollment

64 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Presence of cirrhosis
  • Alveolar-arterial oxygen gradient ≥ 15 mm Hg (≥ 20 mm Hg for age > 64 years)
  • Positive contrast-enhanced echocardiography

Exclusion criteria

  • Age of less than 18 years
  • Intrinsic cardiopulmonary disease
  • Malignancy
  • Active infection
  • Pregnancy
  • Previous shunt therapy
  • Refusal to participate

Trial design

64 participants in 1 patient group

HPS-TIPS group
Treatment:
Procedure: Transjugular intrahepatic portosystemic shunt

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems